BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Loustaud-Ratti V, Debette-Gratien M, Jacques J, Alain S, Marquet P, Sautereau D, Rousseau A, Carrier P. Ribavirin: Past, present and future. World J Hepatol 2016; 8(2): 123-130 [PMID: 26807208 DOI: 10.4254/wjh.v8.i2.123]
URL: https://www.wjgnet.com/1948-5182/full/v8/i2/123.htm
Number Citing Articles
1
Joshua Casaos, Sakibul Huq, Tarik Lott, Raphael Felder, John Choi, Noah Gorelick, Michael Peters, Yuanxuan Xia, Russell Maxwell, Tianna Zhao, Chenchen Ji, Thomas Simon, Julie Sesen, Sarah J. Scotland, Richard E. Kast, Jeffrey Rubens, Eric Raabe, Charles G. Eberhart, Eric M. Jackson, Henry Brem, Betty Tyler, Nicolas Skuli. Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsOncotarget 2018; 9(8): 8054 doi: 10.18632/oncotarget.23883
2
Vishvanath Tiwari. Denovo designing, retrosynthetic analysis, and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2Biology Open 2020;  doi: 10.1242/bio.054056
3
Vishvanath Tiwari. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virusInternational Journal of Biological Macromolecules 2021; 171: 358 doi: 10.1016/j.ijbiomac.2020.12.223
4
Jianguo Chen, Xiaoming Xu, Junjun Chen. Clinically relevant concentration of anti-viral drug ribavirin selectively targets pediatric osteosarcoma and increases chemosensitivityBiochemical and Biophysical Research Communications 2018; 506(3): 604 doi: 10.1016/j.bbrc.2018.10.124
5
Longping V. Tse, Rita M. Meganck, Rachel L. Graham, Ralph S. Baric. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging CoronavirusesFrontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00658
6
Carina Sperotto Librelotto, Daniel Simon, Ana Paula de Souza, Mário Reis Álvares-da-Silva, Rafael Rodrigues Dihl. Chromosomal instability and cytotoxicity induced by ribavirin: comparative analysis in cell lines with different drug-metabolizing profilesDrug and Chemical Toxicology 2019; 42(4): 343 doi: 10.1080/01480545.2017.1405970
7
Pablo Zubiaur, Dora Koller, Miriam Saiz‐Rodríguez, Marcos Navares‐Gómez, Francisco Abad‐Santos. Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19)Clinical and Translational Science 2020; 13(6): 1023 doi: 10.1111/cts.12866
8
Jing Jin, Wei Xiang, Shuang Wu, Min Wang, Meifang Xiao, Ali Deng. Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancerBiochemical and Biophysical Research Communications 2019; 510(4): 580 doi: 10.1016/j.bbrc.2019.01.117
9
Viola Guardigni, Lorenzo Badia, Matteo Conti, Matteo Rinaldi, Rita Mancini, Pierluigi Viale, Gabriella Verucchi. Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antiviralsWorld Journal of Hepatology 2017; 9(34): 1270-1277 doi: 10.4254/wjh.v9.i34.1270
10
F. A. Khaliullin, E. E. Klen, N. N. Makarova. Thietanyl Protection in the Synthesis of 5-Aryloxy(sulfonyl)-3-bromo-1,2,4-triazolesRussian Journal of Organic Chemistry 2018; 54(12): 1856 doi: 10.1134/S1070428018120242
11
J. Cao, X. Sun, X. Zhang, D. Chen. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinomaClinical and Translational Oncology 2018; 20(6): 761 doi: 10.1007/s12094-017-1786-z
12
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, Upadhyayula Suryanarayana Murty, Sucheta Banerjee Kurundkar, Debjani Roy, Pankaj Joshi, Dhananjay Sable, Yogendra Kumar Choudhary, Prashant Kesharwani, Amit Alexander. In-line treatments and clinical initiatives to fight against COVID-19 outbreakRespiratory Medicine 2020; : 106192 doi: 10.1016/j.rmed.2020.106192
13
Yuxi Guo, Xuefeng Chen, Pin Gong. Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungusInternational Journal of Biological Macromolecules 2021; 183: 1753 doi: 10.1016/j.ijbiomac.2021.05.139
14
Sushmita Patra, Rout George Kerry, Ganesh Kumar Maurya, Bijayananda Panigrahi, Swati Kumari, Jyoti Ranjan Rout. Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and InhibitionFrontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.02098
15
Meijun Lu, Qing-Bin Lu, John F. Honek. Squarate-based carbocyclic nucleosides: Syntheses, computational analyses and anticancer/antiviral evaluationBioorganic & Medicinal Chemistry Letters 2017; 27(2): 282 doi: 10.1016/j.bmcl.2016.11.058
16
Zhihua Hu, Lanfang Zhen, Qin Li, Qi Han, Qinquan Hua. Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activationBiochemical and Biophysical Research Communications 2019; 513(4): 862 doi: 10.1016/j.bbrc.2019.04.053
17
Prateek Kumar, Taniya Bhardwaj, Ankur Kumar, Bhuvaneshwari R. Gehi, Shivani K. Kapuganti, Neha Garg, Gopal Nath, Rajanish Giri. Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico studyJournal of Biomolecular Structure and Dynamics 2020; : 1 doi: 10.1080/07391102.2020.1845976
18
Ehab S El Desoky, Alaa T Abdelhafez, Jessica Cusato, Sherif I Kamel, Abeer MR Hussein, Amedeo De Nicolo, Giovanni Di Perri, Antonio D'Avolio. The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patientsClinical and Experimental Pharmacology and Physiology 2017; 44(9): 965 doi: 10.1111/1440-1681.12786
19
Frederick Hansen, Michael A. Jarvis, Heinz Feldmann, Kyle Rosenke. Lassa Virus Treatment OptionsMicroorganisms 2021; 9(4): 772 doi: 10.3390/microorganisms9040772
20
Eloi R Verrier, Amélie Weiss, Charlotte Bach, Laura Heydmann, Vincent Turon-Lagot, Arnaud Kopp, Houssein El Saghire, Emilie Crouchet, Patrick Pessaux, Thomas Garcia, Patrick Pale, Mirjam B Zeisel, Camille Sureau, Catherine Schuster, Laurent Brino, Thomas F Baumert. Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targetsGut 2020; 69(1): 158 doi: 10.1136/gutjnl-2018-317065
21
Omer Basar, Francis Dailey, Erica Dailey, Veysel Tahan, Ebubekir Daglilar. Interferon-Induced Crohn’s Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus InfectionCureus 2021;  doi: 10.7759/cureus.15568
22
Jan Rahmig, Arne Grey, Marco Berning, Jochen Schaefer, Martin Lesser, Heinz Reichmann, Volker Puetz, Kristian Barlinn, Timo Siepmann. Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case reportBMC Neurology 2020; 20(1) doi: 10.1186/s12883-020-01952-5
23
Michael H. J. Rhodin, Nicole V. McAllister, Jonathan Castillo, Sarah L. Noton, Rachel Fearns, In Jong Kim, Jianming Yu, Thomas P. Blaisdell, Joseph Panarese, Brian C. Shook, Yat Sun Or, Bryan Goodwin, Kai Lin, Mark Krystal. EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate modelPLOS Pathogens 2021; 17(3): e1009428 doi: 10.1371/journal.ppat.1009428
24
Suyin Ge, Qingqing Zhang, Yonglin Chen, Yizhen Tian, Ruiying Yang, Xu Chen, Fang Li, Baolai Zhang. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulationToxicology and Applied Pharmacology 2021; 415: 115450 doi: 10.1016/j.taap.2021.115450
25
F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler, N Skuli. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeuticOncogene 2017; 36(21): 3037 doi: 10.1038/onc.2016.457